3 studies found for:    16908937 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Dose Escalation of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib (BAY-43-9006)
2 Completed
Has Results
A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Sorafenib (Nexavar, BAY43-9006)
3 Completed
Has Results
A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
Condition: Carcinoma, Hepatocellular
Interventions: Drug: Sorafenib (Nexavar, BAY43-9006) plus Doxorubicin;   Drug: Doxorubicin/Placebo

Indicates status has not been verified in more than two years